Guangdong VTR Bio-Tech Co Ltd (300381) - Total Assets

Latest as of March 2026: CN¥2.88 Billion CNY ≈ $421.34 Million USD

Based on the latest financial reports, Guangdong VTR Bio-Tech Co Ltd (300381) holds total assets worth CN¥2.88 Billion CNY (≈ $421.34 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Guangdong VTR Bio-Tech Co Ltd - Total Assets Trend (2007–2025)

This chart illustrates how Guangdong VTR Bio-Tech Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Guangdong VTR Bio-Tech Co Ltd (300381) market capitalisation for the company's overall valuation and market capitalisation.

Guangdong VTR Bio-Tech Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Guangdong VTR Bio-Tech Co Ltd's total assets of CN¥2.88 Billion consist of 37.9% current assets and 62.1% non-current assets. Review Guangdong VTR Bio-Tech Co Ltd debt and liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	14.2%
Accounts Receivable	CN¥199.34 Million	6.8%
Inventory	CN¥206.55 Million	7.1%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥332.77 Million	11.4%
Goodwill	CN¥36.67 Million	1.3%

Asset Composition Trend (2007–2025)

This chart illustrates how Guangdong VTR Bio-Tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Guangdong VTR Bio-Tech Co Ltd stock price today for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Guangdong VTR Bio-Tech Co Ltd's current assets represent 37.9% of total assets in 2025, a decrease from 55.7% in 2007.
Cash Position: Cash and equivalents constituted 14.2% of total assets in 2025, up from 13.8% in 2007.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 5.0% in 2007.
Asset Diversification: The largest asset category is intangible assets at 11.4% of total assets.

Guangdong VTR Bio-Tech Co Ltd Competitors by Total Assets

Key competitors of Guangdong VTR Bio-Tech Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Tubize-Fin BR:TUB	Belgium	€1.99 Billion
Dianthus Therapeutics Inc. NASDAQ:DNTH	USA	$1.21 Billion
Tango Therapeutics Inc NASDAQ:TNGX	USA	$1.07 Billion
Damora Therapeutics, Inc. NASDAQ:DMRA	USA	$543.64 Million
Apnimed, Inc. Common Stock NASDAQ:APMD	USA	$342.63 Million
Wecome Pharmaceutical Co Ltd SHE:300878	China	CN¥1.49 Billion
Tectonic Therapeutic, Inc. NASDAQ:TECX	USA	$246.58 Million
Relmada Therapeutics Inc NASDAQ:RLMD	USA	$235.36 Million

Guangdong VTR Bio-Tech Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.91	6.89	2.00
Quick Ratio	3.85	5.77	0.96
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥841.74 Million	CN¥1.05 Billion	CN¥990.38 Million

Guangdong VTR Bio-Tech Co Ltd - Advanced Valuation Insights

This section examines the relationship between Guangdong VTR Bio-Tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.41
Latest Market Cap to Assets Ratio	0.14
Asset Growth Rate (YoY)	-0.8%
Total Assets	CN¥2.92 Billion
Market Capitalization	$398.09 Million USD

Valuation Analysis

Below Book Valuation: The market values Guangdong VTR Bio-Tech Co Ltd's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Guangdong VTR Bio-Tech Co Ltd's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Guangdong VTR Bio-Tech Co Ltd (2007–2025)

The table below shows the annual total assets of Guangdong VTR Bio-Tech Co Ltd from 2007 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥2.92 Billion ≈ $428.01 Million	-0.80%
2024-12-31	CN¥2.95 Billion ≈ $431.47 Million	-4.73%
2023-12-31	CN¥3.09 Billion ≈ $452.89 Million	-2.43%
2022-12-31	CN¥3.17 Billion ≈ $464.18 Million	-29.19%
2021-12-31	CN¥4.48 Billion ≈ $655.56 Million	-4.12%
2020-12-31	CN¥4.67 Billion ≈ $683.69 Million	+3.41%
2019-12-31	CN¥4.52 Billion ≈ $661.14 Million	-5.90%
2018-12-31	CN¥4.80 Billion ≈ $702.55 Million	+24.86%
2017-12-31	CN¥3.85 Billion ≈ $562.68 Million	+19.80%
2016-12-31	CN¥3.21 Billion ≈ $469.70 Million	+30.89%
2015-12-31	CN¥2.45 Billion ≈ $358.84 Million	+154.55%
2014-12-31	CN¥963.36 Million ≈ $140.97 Million	+156.12%
2013-12-31	CN¥376.14 Million ≈ $55.04 Million	+26.92%
2012-12-31	CN¥296.37 Million ≈ $43.37 Million	+14.31%
2011-12-31	CN¥259.27 Million ≈ $37.94 Million	+13.33%
2010-12-31	CN¥228.77 Million ≈ $33.48 Million	+17.38%
2009-12-31	CN¥194.90 Million ≈ $28.52 Million	+14.07%
2008-12-31	CN¥170.86 Million ≈ $25.00 Million	+37.84%
2007-12-31	CN¥123.95 Million ≈ $18.14 Million	--

About Guangdong VTR Bio-Tech Co Ltd

SHE:300381 China Biotechnology

Market Cap

$398.09 Million

CN¥2.72 Billion CNY

Market Cap Rank

#13547 Global

#4060 in China

Share Price

CN¥5.54

Change (1 day)

-0.36%

52-Week Range

CN¥5.40 - CN¥7.55

All Time High

CN¥34.00